FDA

This is historical material, "frozen in time."
The web site is no longer updated and links to external web sites and some internal pages will not work.

T H E W H I T E H O U S E

Food and Drug Administration - Appendix A: Prevention

Help Site Map Text Only

Goal	To reduce transfusion-transmitted HIV infection.
Objective	Ensure supply and safety of the national blood supply.
Action Steps	Establish policies Expedite review of product applications Conduct approval inspections Oversee surveillance Support enforcement activities
*Descriptions*	Encourage high risk donors to exclude themselves; update list of unsuitable donors; quarantine and test blood; investigate incidents to identify, and rectify common errors in blood banks.
Resources	FY95	FY96	FY96
	$ 17.5 million	$ 17.5 million	$ 17.5 million
Populations Served	All persons who may receive blood or blood products.
Constituency Involvement	The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.

President and First Lady | Vice President and Mrs. Gore
Record of Progress | The Briefing Room
Gateway to Government | Contacting the White House
White House for Kids | White House History
White House Tours | Help | Text Only

Privacy Statement

Appendix A: Prevention

CDCC #1- Appendix A: Prevention

FDA